Accès ouvert
2025
article
OpenAlex
Vinathi Polamraju, Neeta A. Vachharajani, Brian F. Gage, Jeffrey S. Crippin et autres
Background COVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status. Methods This single-center retrospective study identified LT recipients with …
us
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Vinathi Polamraju, Neeta A. Vachharajani, Jeffrey S. Crippin, William C. Chapman
Accès ouvert
2023
review
OpenAlex
Vikram S. Pothuri, Michael Anzelmo, Emily Gallaher, Yetunde Ogunlana et autres
us, Nigéria
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Babak John Orandi, Chandler McLeod, Paul A. MacLennan, William M. Lee et autres
Importance: In January 2011, the US Food and Drug Administration (FDA) announced a mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications, with manufacturer compliance required by March 2014. Objective: To assess the odds of hospitalization and …
us, ca
(code pays fourni par la source)
2021
article
OpenAlex
Motaz H. Ashkar, Jacqueline M. Chen, Corey Shy, Jeffrey S. Crippin et autres
us
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Megan E White, Jeffrey S. Crippin, Scott A. Mchenry
Accès ouvert
2021
article
OpenAlex
Oliver D. Tavabie, Constantine Jason Karvellas, Jaime Lynn Speiser, Christopher F. Rose et autres
gb, ca, us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Andrew J. MacDonald, Jaime Lynn Speiser, Daniel R. Ganger, Kathleen M. Nilles et autres
us, ca
(code pays fourni par la source)
2020
conference-abstract
OpenAlex
Motaz H. Ashkar, Jacqueline M. Chen, Corey Shy, Jeffrey S. Crippin et autres
Accès ouvert
2020
article
OpenAlex
Adeel S. Khan, Nathaniel Adams, Neeta A. Vachharajani, LeighAnne Dageforde et autres
INTRODUCTION: Direct-acting antivirals (DAA's) have revolutionized hepatitis-C virus (HCV) treatment, however controversy remains regarding timing of treatment in relation to liver-transplant (LT). METHODS: Single-center retrospective study assessing outcomes of listed HCV positive patients in the DAA-era (2014-2017). Patients treated with DAA's before …
us
(code pays fourni par la source)
Accès ouvert
2019
conference-abstract
OpenAlex
Elaine Shao, I-Ling Chiang, Noor J. Al-Hammadi, Ted Walker et autres
2019
article
OpenAlex
Saad Ali Alghamdi, Osama Altayar, Alexis Bayudan, Jaquelyn Fitch Fleckenstein et autres